Hostname: page-component-77f85d65b8-jkvpf Total loading time: 0 Render date: 2026-04-13T16:45:57.622Z Has data issue: false hasContentIssue false

KTP laser therapy for refractory chronic myringitis: a case series and comparative outcomes

Published online by Cambridge University Press:  05 November 2025

Justin Tze Tao Wong
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Kowloon West Cluster, Hong Kong, China
Sung Him Herbert Lee*
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Kowloon West Cluster, Hong Kong, China
Hilary Hil Ching Kwok
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Kowloon West Cluster, Hong Kong, China
Cynthia Ka Cheong Wai
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Kowloon West Cluster, Hong Kong, China
*
Corresponding author: Sung Him Herbert Lee; Email: herbertshlee@gmail.com

Abstract

Objectives

The aim of this study was to compare KTP (potassium titanyl phosphate) laser therapy and dextracin ear drops for treatment of chronic myringitis.

Methods

A case series involving 31 patients (18 laser group; 13 dextracin group). Primary outcomes included otorrhoea resolution, improvement in Chronic Ear Survey scores and endoscopic resolution. Secondary outcomes included hearing outcome and complications. Statistical analyses were performed using Mann-Whitney U, Wilcoxon signed-rank and Fisher’s exact tests.

Results

The laser group had a higher rate of otorrhoea resolution 66.67 per cent (n = 12) vs 15.38 per cent (n = 2) (p = 0.006), showed significant improvement in symptom scores (median 31.43; p = 0.005) and medical resource use (16.67; p < 0.001) and had a significant myringitis area reduction of 31.84 per cent (p < 0.001). No significant differences were observed in Chronic Ear Survey scores and area reduction in the dextracin group. One laser-group patient developed a permanent perforation.

Conclusion

KTP laser therapy is effective for refractory chronic myringitis, offering superior symptom relief and reduced healthcare utilisation compared to topical treatment.

Information

Type
Main Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Herbert S H Lee takes responsibility for the integrity of the content of the paper

References

Ling, SW, Lim, CC, Mohd Damanhuri Shah, MFSB, Devesahayam, PR. Refractory chronic diffuse granular myringitis with medial meatal stenosis. J Int Adv Otol 2024;20:458–61CrossRefGoogle Scholar
Devaraja, K. Myringitis: an update. J Otol 2019;14:26–9CrossRefGoogle ScholarPubMed
Ghedia, R, Sutton, L, Hogan, C, Seymour, K, Wareing, M. Potassium titanyl phosphate laser surface tympanoplasty as a novel treatment for chronic granular myringitis in a series of 14 patients. J Laryngol Otol 2022;136:1044–50CrossRefGoogle Scholar
Jang, CH, Kim, YH, Cho, YB, Wang, PC. Endoscopy-aided laser therapy for intractable granular myringitis. J Laryngol Otol 2006;120:553–5CrossRefGoogle ScholarPubMed
Chung, J, Lee, DY, Kim, YH. Management of myringitis: current concepts and review. Laryngoscope 2018;128:2157–62CrossRefGoogle ScholarPubMed
Wolf, M, Primov-Fever, A, Barshack, I, Polack-Charcon, S, Kronenberg, J. Granular myringitis: incidence and clinical characteristics. Otol Neurotol 2006;27:1094–7CrossRefGoogle ScholarPubMed
Kim, YH. Clinical characteristics of granular myringitis treated with castellani solution. Eur Arch Otorhinolaryngol 2011;268:1139–46CrossRefGoogle ScholarPubMed
El-Seifi, A, Fouad, B. Granular myringitis: is it a surgical problem? Am J Otol 2000;21:462–7Google ScholarPubMed